| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 From The Rush Heart Institute, Rush-Presbyterian-St. Luke's Medical Center, Chicago
2 From the University of Illinois at Chicago
3 From the University of Minnesota, Minneapolis
Stuart Rich, MD, FCCP, The Rush Heart Institute, Center for Pulmonary Heart Disease, Rush-Presbyterian-St. Luke's Medical Center, 1725 W Harrison St, Suite 020, Chicago, IL 60612-3824; email: srich{at}rpslmc.edu
Objective: Studies on the effects of digoxin in patients with right ventricular failure and normal left ventricular function have not been performed. We evaluated the short-term effects of digoxin administration in patients with primary pulmonary hypertension on hemodynamics, neurohormones, and baroreceptor responsiveness.
Design: This was a prospective study with patients serving as their own controls.
Setting: University Hospital Intensive Care Unit with central monitoring.
Patients: Seventeen patients with primary pulmonary hypertension and symptomatic heart failure were enrolled.
Interventions: Following baseline hemodynamics, neurohormonal samples were drawn and the heart rate response to change in blood pressure following a challenge of phenylephrine and nitroprusside were recorded. One mg of intravenous digoxin was given and the measurements repeated after 2 hours.
Results: Following digoxin there was a significant increase in cardiac output (3.49±1.2 to 3.81±1.2 L/min., p=0.028), a significant fall in norepinephrine (680±89 to 580±85 pg/ml, p=.013), and a significant increase in atrial natriuretic peptide (311±44 to 421±9 pg/ml, p=0.01). All of the patients had changes in heart rate and blood pressure following phenylephrine and nitroprusside challenge, but there was no significant difference in the change in heart rate response to change in blood pressure when rechallenged after digoxin treatment.
Conclusion: Digoxin produces a modest increase in cardiac output in patients with pulmonary hypertension and right ventricular failure, as well as a significant reduction in circulating norepinephrine. No detectable effects of digoxin on baroreceptor responsiveness were apparent. The use of digoxin in pulmonary hypertension is warranted.
Key Words: digoxin • heart failure • pulmonary heart disease
This article has been cited by other articles:
|
|
 |
|
  L. J. Rubin and D. B. Badesch Evaluation and Management of the Patient with Pulmonary Arterial Hypertension Ann Intern Med, August 16, 2005; 143(4): 282 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Rodriguez-Roisin, M.J. Krowka, Ph. Herve, M.B. Fallon, and on behalf of the ERS Task Force Pulmonary-Hepatic Pulmonary-Hepatic vascular Disorders (PHD) Eur. Respir. J., November 1, 2004; 24(5): 861 - 880. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gheorghiade, K. F. Adams Jr, and W. S. Colucci Digoxin in the Management of Cardiovascular Disorders Circulation, June 22, 2004; 109(24): 2959 - 2964. [Full Text] [PDF]
|
|
|
|
|
|
N. Nagaya, S. Kyotani, M. Uematsu, K. Ueno, H. Oya, N. Nakanishi, M. Shirai, H. Mori, K. Miyatake, and K. Kangawa Effects of Adrenomedullin Inhalation on Hemodynamics and Exercise Capacity in Patients With Idiopathic Pulmonary Arterial Hypertension Circulation, January 27, 2004; 109(3): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A K Siddiqui and S Ahmed Pulmonary manifestations of sickle cell disease Postgrad. Med. J., July 1, 2003; 79(933): 384 - 390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Widlitz and R.J. Barst Pulmonary arterial hypertension in children Eur. Respir. J., January 1, 2003; 21(1): 155 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chatterjee, T. De Marco, and J. S. Alpert Pulmonary Hypertension: Hemodynamic Diagnosis and Management Arch Intern Med, September 23, 2002; 162(17): 1925 - 1933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.M. Hoeper Pulmonary hypertension in collagen vascular disease Eur. Respir. J., March 1, 2002; 19(3): 571 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Bossone, G. Paciocco, D. Iarussi, A. Agretto, A. Iacono, B. W. Gillespie, and M. Rubenfire The Prognostic Role of the ECG in Primary Pulmonary Hypertension Chest, February 1, 2002; 121(2): 513 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gomez, D. Bialostozky, A. Zajarias, E. Santos, A. Palomar, M. L. Martinez, and J. Sandoval Right ventricular ischemia in patients with primary pulmonary hypertension J. Am. Coll. Cardiol., October 1, 2001; 38(4): 1137 - 1142. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 British Cardiac Society Guidelines and Medical Pra Recommendations on the management of pulmonary hypertension in clinical practice Heart, September 1, 2001; 86(90001): i1 - 13. [Full Text] [PDF]
|
|
|
|
|
|
S. Archer and S. Rich Primary Pulmonary Hypertension : A Vascular Biology and Translational Research "Work in Progress" Circulation, November 28, 2000; 102(22): 2781 - 2791. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A J Peacock Rare diseases bullet 5: Primary pulmonary hypertension Thorax, December 1, 1999; 54(12): 1107 - 1118. [Full Text]
|
|
|
|
 |
|
 B. S. Huang, M. Kudlac, R. Kumarathasan, and F. H. H. Leenen Digoxin Prevents Ouabain and High Salt Intake-Induced Hypertension in Rats With Sinoaortic Denervation Hypertension, October 1, 1999; 34(4): 733 - 738. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
